Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy

Tadahiko Yanagita(Toxicologie, Pharmacologie et Signalisation Cellulaire), Takashi Matozaki(Kobe University)
JCI Insight
January 11, 2017
Cited by 152


Related Papers